Journal of Stroke and Cerebrovascular Diseases

Publisher: W.B. Saunders
Country: United States · Northern America
Type: journal
ISSN: 10523057

15328511

Scopus 0,69 SJR

Scopus Q1 SJR Q

WoS Q3 JCR Q

WoS 2,1 JIF

Scopus 89 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

SJR 0,69
Quartile Q1
H-Index 89
Cites/doc 2,14
Docs (3y) 1.440
Cites (3y) 3.166

Clarivate

Web of Science · JCR · 2025

JCR Q Q3
JIF 2,1
5Y JIF 2,3
JCI 0,5

WoS indexes

SCIE

Subject classification

Categories (SJR)

Cardiology and Cardiovascular Medicine Q2
Neurology (clinical) Q2
Rehabilitation Q1
Surgery Q1

Areas

Medicine

WoS categories

Neurosciences | Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q1	Q3	0,69	2,1	2,3	0,5	Q3	89
2024	Q1	Q3	0,688	1,8	2,1	0,52	Q3	85
2023	Q1	Q3	0,678	2	2,1	0,54	Q2	85
2022	Q1	Q3	0,713	2,5	2,4	0,55	Q2	85
2021	Q1	Q3	0,698	2,7	2,5	0,51	Q3	85
2020	Q1	Q4	0,765	2,1	2,2	0,48	Q3	85
2019	Q2	Q4	0,651	1,8	1,8	0,47	Q3	85
2018	—	Q4	—	1,6	1,8	0,44	Q3	—
2017	Q2	Q4	0,732	1,6	1,7	0,42	Q3	85
2016	Q1	Q4	0,806	1,5	1,7	—	—	85
2015	Q1	Q3	0,793	1,6	1,7	—	—	85
2014	Q1	Q4	0,843	1,7	1,8	—	—	85
2013	Q1	Q3	0,836	2	—	—	—	85
2012	Q1	Q3	0,888	2	—	—	—	85
2011	Q1	Q3	0,863	1,7	—	—	—	85
2010	Q1	—	0,698	—	—	—	—	85

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year	Category	Edition	JCR Q (1997+)	JCI Q (1997+)	Rank
2025	NEUROSCIENCES	SCIE	Q3	Q4	246/330
2025	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	Q3	57/100
2024	NEUROSCIENCES	SCIE	Q4	Q4	254/314
2024	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	Q3	64/98
2023	NEUROSCIENCES	SCIE	Q3	Q4	228/310
2023	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	Q2	55/96
2022	NEUROSCIENCES	SCIE	Q3	Q4	198/272
2022	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	Q2	45/68
2021	NEUROSCIENCES	SCIE	Q4	Q4	212/275
2021	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	Q3	47/67
2020	NEUROSCIENCES	SCIE	Q4	Q4	225/273
2020	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q3	50/65
2019	NEUROSCIENCES	SCIE	Q4	Q4	221/272
2019	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q3	50/65
2018	NEUROSCIENCES	SCIE	Q4	Q4	227/267
2018	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q3	49/65
2017	NEUROSCIENCES	SCIE	Q4	Q4	223/261
2017	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q3	49/65
2016	NEUROSCIENCES	SCIE	Q4	—	216/259
2016	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	50/63
2015	NEUROSCIENCES	SCIE	Q4	—	205/256
2015	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	—	47/63
2014	NEUROSCIENCES	SCIE	Q4	—	194/252
2014	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	47/60
2013	NEUROSCIENCES	SCIE	Q3	—	181/252
2013	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	—	42/65
2012	NEUROSCIENCES	SCIE	Q3	—	180/252
2012	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	—	40/68
2011	NEUROSCIENCES	SCIE	Q4	—	188/244
2011	PERIPHERAL VASCULAR DISEASE	SCIE	Q3	—	43/68